Sanofi's Chew on Auvi-Q Voice-Guided Injector

Aug. 15 (Bloomberg) -- Paul Chew, chief science officer for Sanofi Aventis USA, talks about the company's Auvi-Q injection system for the emergency treatment of life-threatening allergic reactions. Auvi-Q is the first and only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers through the injection process. Chew speaks with Dominic Chu on Bloomberg Television's "Bottom Line." Mark Crumpton also speaks. (Source: Bloomberg)
Kaisa Misses 2014 Result Release, Shares Suspended
39:36 - Shares of Troubled developer Kaisa are suspended today as the company says it won't be able to release 2014 results as expected, indicating more balance sheet complications. Bloomberg's Christine Hah reports on "Trending Business." (Source: Bloomberg)
  • IPhone 6 Sales Drive Hon Hai Profit to Record
  • Deadline Looms for Countries to Join AIIB
  • Hanergy's Profit Surge Raises Valuation Concerns